ArticleScientific reports2026

Hepatic and metabolic effects of SGLT2 inhibitors in type 2 diabetes and MASLD assessed by metabolomic and lipidomic analysis.

Kenan Moral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.